LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.99 | 84.90 | 7168 | 8212 | 0.8728 | 0.9592 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.99 | 84.90 | 8233 | 8212 | 1.0025 | 1.0008 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 63.99 | 84.90 | 8301 | 8212 | 1.0108 | 1.0033 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.70 | 84.90 | 272 | 8484 | 0.0321 | 0.1916 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.70 | 84.90 | 7430 | 8484 | 0.8757 | 0.9605 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.70 | 84.90 | 8464 | 8484 | 0.9976 | 0.9993 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 65.70 | 84.90 | 8535 | 8484 | 1.0060 | 1.0018 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.41 | 84.90 | 285 | 8766 | 0.0325 | 0.1984 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.41 | 84.90 | 7664 | 8766 | 0.8743 | 0.9602 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.41 | 84.90 | 8646 | 8766 | 0.9863 | 0.9959 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 67.41 | 84.90 | 8738 | 8766 | 0.9968 | 0.9990 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 281 | 8988 | 0.0313 | 0.1948 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 7962 | 8988 | 0.8859 | 0.9643 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 8796 | 8988 | 0.9786 | 0.9936 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 69.11 | 84.90 | 8902 | 8988 | 0.9904 | 0.9971 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.81 | 84.90 | 295 | 9132 | 0.0323 | 0.2027 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.81 | 84.90 | 8152 | 9132 | 0.8927 | 0.9666 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.81 | 84.90 | 8934 | 9132 | 0.9783 | 0.9935 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 70.81 | 84.90 | 9073 | 9132 | 0.9935 | 0.9981 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.52 | 84.90 | 310 | 9214 | 0.0336 | 0.2111 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.52 | 84.90 | 8271 | 9214 | 0.8976 | 0.9683 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.52 | 84.90 | 9124 | 9214 | 0.9902 | 0.9971 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 72.52 | 84.90 | 9276 | 9214 | 1.0067 | 1.0020 | MN20160318_Q02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 74.22 | 84.90 | 256 | 9343 | 0.0274 | 0.1767 | MN20160318_Q02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 74.22 | 84.90 | 8416 | 9343 | 0.9007 | 0.9694 | MN20160318_Q02 | D22 |